A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.
about
Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesisA novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell typesEBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance.Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic miceThe cellular proteins that bind specifically to the Epstein-Barr virus origin of plasmid DNA replication belong to a gene familyAnalysis of mutation in human cells by using an Epstein-Barr virus shuttle systemPlasticity of DNA replication initiation in Epstein-Barr virus episomesLack of evidence for an association of Epstein-Barr virus infection with breast carcinomaKaposi's Sarcoma Herpesvirus Genome PersistenceNovel mechanisms of EBV-induced oncogenesisStable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapyEpstein-Barr virus latent genesModulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alphaAntigen-binding properties of monoclonal antibodies reactive with EBNA1 and use in immunoaffinity chromatographyHuman induced pluripotent stem cells free of vector and transgene sequencesAnalysis of human cytomegalovirus oriLyt sequence requirements in the context of the viral genome.Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes.In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.Construction of a directed hammerhead ribozyme library: towards the identification of optimal target sites for antisense-mediated gene inhibition.A role for MRE11, NBS1, and recombination junctions in replication and stable maintenance of EBV episomes.Regulated expression of a transgene introduced on an oriP/EBNA-1 PAC shuttle vector into human cells.BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.Gene-delivery systems for iPS cell generation.Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.A role for DNA polymerase θ in promoting replication through oxidative DNA lesion, thymine glycol, in human cells.Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice.Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin.Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenanceThe minimal replicator of Epstein-Barr virus oriP.Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells.The replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements.An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3AEBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines.The dyad symmetry element of Epstein-Barr virus is a dominant but dispensable replication origin.Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.Episomal vectors for gene expression in mammalian cells.
P2860
Q24291532-AD714FAB-6947-4276-9929-6BEC903DA82FQ24309431-E2622C24-BE63-4AD5-A3F6-906C836E636BQ24517055-83385D96-04E2-471E-A8A4-A18AFC4A4C54Q24520598-6B6F4617-CFD1-42B0-B152-7C8054085F9FQ24562912-378D475E-E99F-4BF4-A775-8F7D28537F3EQ24563778-9E6390FC-6977-48A4-A88B-1AFEF03655A7Q24628961-084E55BB-AAEA-48DA-8E26-B2A97C3F7871Q24793031-22213FA0-52CD-4310-98D8-ACF73574B776Q24795212-5B344CA7-E7FB-4E0D-A82D-80351279F4BFQ26738483-D8026BF4-4B04-4315-96BC-2D54A5C9DF92Q27006524-E74B2A5B-B8EB-496D-9A04-30E2896F7288Q27490200-4B7767AF-7FBF-45F5-9683-54E3DAFD4E65Q28082701-4B003BA0-00C8-44CB-B073-6DD2261D3275Q28117643-C86E7224-53D6-4F03-8547-873D6A3B58B3Q28474869-D13DE8E0-626E-44E2-BCA1-609DB8F05E0BQ29547624-3BC58AEF-7901-455C-AEBD-0E144809815CQ30320280-2CD91DB1-A36B-4CC5-9C08-6D96C83B33D4Q30398275-0CC6F96F-CF29-4BC3-B556-CF830C9F63B8Q31122638-50CE0B2F-A9E6-4C3A-B348-2CE1A908957EQ31982706-27FA3186-BAA2-468A-B87E-1DE97CE4E2E2Q33307378-C4AC85D1-500D-4169-A262-A54DD124CCC9Q33511029-CA9DA347-84A2-408D-BB6D-E81F2AAFA91EQ33552058-93818890-271A-4274-8393-F3CE4247FADDQ33611081-0803FC79-E1F9-44C6-A7E3-7320A8AC5BD3Q33652811-C7867251-9EBD-4530-8AEF-D665173B638AQ33676609-136E20FB-54D9-41EF-BDD6-BBF8F1909942Q33756914-9197095A-BBBB-4DD6-A009-0E9123B25C23Q33781363-29FC12BC-A569-46BE-8C00-7894BC502FADQ33786506-6BC3A57D-0D67-476A-A9E6-8E9EE59E08DAQ33804269-07156BF9-EE50-4F0C-8C50-C1B241B958B2Q33836726-3041FF21-0838-4478-B6AA-6C48FC6C9FA4Q33838228-45F88324-A6BC-436A-87E7-1B19D1D64FEDQ33844249-1AECD618-EDF1-4C8A-810F-41CA0836BC63Q33848552-6A4B216B-BC3D-45FC-8B6D-BDC195CB7069Q33854424-35097509-5294-42DD-BBE6-A662657B5A0BQ33860748-17C39FAF-B915-43C8-9A7F-92DB6A50C318Q33866311-824F223F-BFB2-4047-B692-262D1B62B3F1Q33908615-EA33FCCE-4580-41B0-9B22-85493671CDC6Q33911843-7EE69812-3CB5-4406-9256-5F4695E262D1Q33916410-2CF83360-BA8F-43B4-B4EE-1B5DC92A9C23
P2860
A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
A cis-acting element from the ...... ds in latently infected cells.
@ast
A cis-acting element from the ...... ds in latently infected cells.
@en
type
label
A cis-acting element from the ...... ds in latently infected cells.
@ast
A cis-acting element from the ...... ds in latently infected cells.
@en
prefLabel
A cis-acting element from the ...... ds in latently infected cells.
@ast
A cis-acting element from the ...... ds in latently infected cells.
@en
P2093
P2860
P356
P1476
A cis-acting element from the ...... ds in latently infected cells.
@en
P2093
P2860
P304
P356
10.1073/PNAS.81.12.3806
P407
P577
1984-06-01T00:00:00Z